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K-variant BCHE and pesticide 
exposure: Gene-environment 
interactions in a case–control study 
of Parkinson’s disease in Egypt
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El-Tantawy7, Gharib Fawi8, Amal El-Motayam9, Ehab El-Seidy10, Mohamed El-Sherif7, 
Mohamed El-Gamal4, Mohamed Moharram4, Mohammad El-Kattan4, Muhammad Abdel-
Naby4, Samia Ashour5, Ulrich Müller11, Astrid Dempfle  12, Gregor Kuhlenbäumer13 & 
Günter U. Höglinger  1,2,14
Pesticide exposure is associated with increased risk of Parkinson’s disease (PD). We investigated in 
Egypt whether common variants in genes involved in pesticide detoxification or transport might modify 
the risk of PD evoked by pesticide exposure. We recruited 416 PD patients and 445 controls. Information 
on environmental factors was collected by questionnaire-based structured interviews. Candidate 
single-nucleotide polymorphisms (SNPs) in 15 pesticide-related genes were genotyped. We analyzed 
the influence of environmental factors and SNPs as well as the interaction of pesticide exposure 
and SNPs on the risk of PD. The risk of PD was reduced by coffee consumption [OR = 0.63, 95% CI: 
0.43–0.90, P = 0.013] and increased by pesticide exposure [OR = 7.09, 95% CI: 1.12–44.01, P = 0.036]. 
The SNP rs1126680 in the butyrylcholinesterase gene BCHE reduced the risk of PD irrespective of 
pesticide exposure [OR = 0.38, 95% CI: 0.20–0.70, P = 0.002]. The SNP rs1803274, defining K-variant 
BCHE, interacted significantly with pesticide exposure (P = 0.007) and increased the risk of PD only in 
pesticide-exposed individuals [OR = 2.49, 95% CI: 1.50–4.19, P = 0.0005]. The K-variant BCHE reduces 
serum activity of butyrylcholinesterase, a known bioscavenger for pesticides. Individuals with K-variant 
BCHE appear to have an increased risk for PD when exposed to pesticides.
Parkinson’s disease (PD) is a progressive neurodegenerative disease with intraneuronal aggregation of 
alpha-synuclein, and characteristic motor and non-motor symptoms, affecting more than 6.2 million people glob-
ally1. Monogenic inheritance only accounts for a small proportion of PD cases, whereas the etiology in more than 
90% of the patients appears as complex interplay of multiple genetic and environmental risk factors2. Knowledge 
about causative factors is of utmost relevance to develop preventive measures and disease-modifying therapies.
In the 1980s, 1-methyl-4-phenylpyridinium (MPP+) was discovered to induce neurodegeneration and parkin-
sonism in drug abusers3. MPP+ was marketed as pesticide under the tradename cyperquat4 and showed structural 
similarities to other known pesticides, e.g. paraquat. This finding triggered intensive research about potential 
1German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. 2Department of Neurology, Technical 
University of Munich, Munich, Germany. 3Medical Experimental Research Center (MERC), Mansoura University, 
Mansoura, Egypt. 4Toxicology Department, Mansoura University, Mansoura, Egypt. 5Department of Neurology, 
Ain Shams University, Cairo, Egypt. 6Department of Neurology, Assiut University, Assiut, Egypt. 7Department of 
Neurology, Mansoura University, Mansoura, Egypt. 8Department of Neurology, Sohag University, Sohag, Egypt. 
9Department of Neurology, Zagazig University, Zagazig, Egypt. 10Department of Neurology, Tanta University, Tanta, 
Egypt. 11Institute for Human Genetics, Justus Liebig University Giessen, Giessen, Germany. 12Institute of Medical 
Informatics and Statistics, Kiel University, Kiel, Germany. 13Department of Neurology, Kiel University, Kiel, Germany. 
14Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-University, Munich, Germany. Thomas W. 
Rösler and Mohamed Salama contributed equally. Gregor Kuhlenbäumer and Günter U. Höglinger jointly supervised 
this work. Correspondence and requests for materials should be addressed to G.U.H. (email: guenter.hoeglinger@
dzne.de)
Received: 18 July 2018
Accepted: 29 October 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIENTIfIC REPoRTS |         (2018) 8:16525  | DOI:10.1038/s41598-018-35003-4
links between pesticides and PD. Three meta-analyses of epidemiological studies investigating the association of 
pesticides and PD have been carried out so far5,6. They consistently concluded that pesticide exposure and factors 
related to pesticide exposure (e.g. rural living, farming or well water drinking) are positively associated with the 
risk to develop PD5,6.
Recent studies investigated whether risk conferred by pesticide exposure is modified by single nucleotide 
polymorphisms (SNPs) in candidate genes involved in detoxification or neuronal uptake of pesticides (e.g. alde-
hyde dehydrogenase 2 (ALDH2)7, cytochrome P450 2 D6 (CYP2D6)8, manganese-dependent superoxide dismu-
tase (MnSOD)9, nitric oxide synthase 1 (NOS1)10, NAD(P)H dehydrogenase [quinone] 1 (NQO1)9, multidrug 
resistance protein 1 (MDR1)11, glutathione-S-transferase (GST)12, paraoxonase 1 (PON1)13, dopamine transporter 
(SLC6A3)14. Some studies found an interaction of pesticide exposure with genetic variants in ALDH27, CYP2D68, 
NOS110, PON1 concerning PD risk13. Most studies, however, did not find significant gene-environment interac-
tions. A recent study searched genome-wide for genetic modifiers of PD risk conferred by pesticides in a relatively 
small number of patients, without finding any significant results15.
In Egypt, pesticides are used extensively and under low safety standards, including types of pesticides that 
have been banned in Western countries for many years due to safety concerns16. Presently, around 40% of the 
Egyptian workforce is employed in agriculture with high likeliness of pesticide exposure17. Furthermore, Egypt 
has an age-adjusted prevalence (≥50 years) of 2,500-2,750 PD cases per 100,000 in distinct governorates18,19, with 
a three-fold excess in rural over urban residence, which represents a massive increase by international compari-
son, particularly also compared to surrounding Arab countries20. Therefore, we collected a case-control sample 
in Egypt to study the association of PD with exposure to pesticides and their interaction with genetic variants 
involved in pesticide metabolism. Genes and variants of interest were selected by a detailed literature research on 
genes important for pesticide detoxification with a possible relation to neurodegeneration.
Results
Participants’ characteristics. The study sample consisted of n = 416 unrelated PD patients and n = 445 
unrelated healthy controls of Egyptian ancestry (Table 1). The sex distribution did not differ between the groups, 
but PD patients were older than controls. Age at diagnosis, disease duration, and Hoehn and Yahr stage distribu-
tion for the PD patients are shown in Table 1.
Environmental factors affect the risk of PD. In a first exploratory comparison, we analyzed differences 
in single environmental factors between PD patients and control individuals (Table 1). Coffee consumption was 
the only factor associated with a decreased risk of PD. Factors associated with increased risk of PD were age, well 
water drinking, illiteracy, use of pesticides at work, and specifically the use of herbicides at home and/or at work. 
The use of insecticides at home and/or at work showed a trend towards a positive association with PD.
We then constructed a logistic regression model to assess the composite influence of environmental factors on 
the risk for PD. We considered all factors, which were significantly associated with PD in the single factor analysis 
(Table 1) for the model.
Well water drinking was significantly associated with PD, but 25 out of 27 well water drinkers (93%) were 
also exposed to pesticides, leading to high collinearity (P < 0.001) between these factors, with pesticide exposure 
rather than well water drinking being the likely causal risk factor for PD2,5. Illiteracy was also highly collinear with 
pesticide exposure (P < 0.001), with 85% of the illiterate participants being pesticide exposed. Again, pesticide 
exposure rather than illiteracy was the biologically plausible risk factor2,5. Therefore, well water drinking and 
illiteracy were excluded from the logistic regression model.
In our cohort, 79% of the coffee drinkers were not pesticide-exposed. Thus, coffee consumption was inversely 
correlated with pesticide exposure (P < 0.001). Nevertheless, we included coffee in the regression model because it 
is a well-known protective factor for PD2,5. Age was expectedly a highly significant risk factor for PD (P < 0.001). 
In addition, age interacted with pesticide exposure (P = 0.031) as explanatory variables for PD risk. Age was a 
somewhat stronger risk factor in the pesticide exposed subgroup (OR for 10 years age difference in the exposed 
subgroup: 2.95, 95% confidence interval: 2.39–3.71; in the unexposed subgroup: 2.56, 95% confidence interval: 
1.18–3.02).
Consequently, the final logistic regression model contained pesticide exposure, coffee consumption, age, and 
the interaction (age x pesticide exposure). In this analysis, age and pesticide exposure were confirmed as signifi-
cant risk factors for PD, while coffee consumption was protective (Table 2).
Influence of protective measures on PD risk. To identify factors modulating the risk for PD caused by 
occupational pesticide exposure, we compared protective measures in the subgroups of occupationally exposed 
participants, all of whom worked with pesticides in agriculture (n = 156 overall, n = 87 PD, n = 69 controls). Most 
of them had worked for more than 20 years with pesticides (90.8% of PD patients, 91.3% of controls). Their risk 
for PD was significantly reduced by wearing gloves during work and by washing hands after work, but not by 
changing clothes and taking a shower after work (Table 3).
Effect of variants in BCHE on PD risk. Next, we investigated the influence of genetic factors and gene- 
environment interactions on the risk to develop PD. After marker- and sample-wise quality control of the geno-
typing data, n = 372 PD patients and n = 394 control individuals remained, of whom n = 275 (n = 147 PD, n = 128 
controls) had been exposed to pesticides. We expanded the logistic regression model described above by the 
SNP data and by an interaction term (SNP × pesticide exposure). We analyzed the dominant model for all SNPs 
(Supplementary Table S1).
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Only the SNP rs1126680 in the butyrylcholinesterase gene (BCHE) showed significant association with PD 
per se (Table 4; minor allele (G) frequency 0.140 in controls, 0.060 in PD; P = 0.007, OR = 0.38, 95% confidence 
interval: 0.20–0.70).
SNP rs1803274 was not associated with PD per se (minor allele (A) frequency 0.241 in controls, 0.250 in PD), 
but interacted significantly with pesticide exposure (Table 4; interaction: P = 0.007 dominant). In carriers of the 
minor allele of rs1803274, pesticide exposure significantly increased the risk of PD (Fig. 1a; P = 0.0005, OR = 2.49, 
95% confidence interval: 1.50–4.19) compared to unexposed individuals with the same genotype.
In addition, we performed a subgroup analysis comparing non-exposed participants specifically to partici-
pants exposed only to insecticides or to herbicides, respectively. The interaction of rs1803274 was significant in 
the insecticide only exposed subgroup (Table 4; P interaction = 0.002), but not in the herbicide-exposed subgroup 
(Table 4; P interaction = 0.893). In carriers of the minor allele of rs1803274, insecticide exposure increased the 
Characteristic
PD cases 
(n = 416)
Controls 
(n = 445) OR 95% CI P-Value
Sex (male) [n (%)] 253 (60.8) 263 (59.1) 1.074 (0.82–1.41) 0.608
Age (y) [mean (SD)] 58.4 (8.8) 48.6 (11.8) 2.56* (2.18–3.02) <0.001*
Age at diagnosis (y) [mean (SD)] 55.0 (8.8) n.a.
Disease duration (y) [mean (SD)] 3.5 (2.8) n.a.
Hoehn & Yahr stage
   Stage 1 [n (%)] 121 (29.1) n.a.
   Stage 1.5 [n (%)] 111 (26.7) n.a.
   Stage 2 [n (%)] 107 (25.7) n.a.
   Stage 2.5 [n (%)] 20 (4.8) n.a.
   Stage 3 [n (%)] 40 (9.6) n.a.
   Stage 4 [n (%)] 14 (3.4) n.a.
   Stage 5 [n (%)] 3 (0.7) n.a.
Head trauma [n (%)] 10(2.4) 19 (4.3) 0.55 (0.24–1.17) 0.135
Rural living
   Most of life [n (%)] 142 (34.1) 135 (30.3) 1.19 (0.89–1.59) 0.233
   Childhood [n (%)] 138 (33.2) 135 (30.3) 1.14 (0.86–1.52) 0.372
Well water drinking [n (%)] 27 (6.5) 0 (0.0) n.a. n.a. <0.001‡
Illiteracy [n (%)] 129 (31.0) 100 (22.5) 1.55 (1.14–2.11) 0.005
Coffee consumption [n (%)] 66 (15.9) 134 (30.1) 0.44 (0.31–0.61) <0.001
Black tea consumption [n (%)] 391 (94.0) 418 (93.9) 1.01 (0.58–1.77) 0.972
Cigarette smoking [n (%)] 69 (16.6) 78 (17.5) 0.94 (0.65–1.33) 0.714
Shisha smoking [n (%)] 39 (9.4) 31 (7.0) 1.38 (0.85–2.27) 0.198
Pesticide exposure# 163 (39.2) 148 (33.2) 1.29 (0.98 1.71) 0.071
Use of pesticides vs. non-exposed
   At home only [n (%)] 44 (14.8) 48 (13.9) 1.08 (0.69–1.68) 0.745
   At work [n (%)] 87 (25.6) 69 (18.8) 1.48 (1.04–2.12) 0.032
Pesticide classes used at home or/and at work vs. non-exposed
   Insecticides only [n (%)] 82 (24.5) 104 (25.9) 0.93 (0.66–1.29) 0.926
   Herbicides and other [n (%)] 46 (15.4) 11 (3.6) 4.91 (2.58–9.94) <0.001
Table 1. Participants’ characteristics. Odds ratio (OR), 95% confidence interval (CI) and P-value were 
calculated using logistic regression; *OR and CI calculated by logistic regression analysis for the ~10-year age 
difference between cases and controls. #Ever use of pesticides at home or at work, or >50% lifetime residence 
in rural areas. ‡Calculated using Fisher’s exact test because the logistic regression did not converge. The odds 
ratio for well water drinking could not be calculated because none of the controls drank well water. n.a., not 
applicable.
Variable OR 95% CI P-Value
Age 2.86+ (2.31–3.61) 2 × 10−16
Coffee consumption 0.63 (0.43–0.90) 0.013
Pesticide exposure* 7.09 (1.12–44.01) 0.036
Table 2. Environmental factors affecting the risk for PD. Statistical analysis was carried out by logistic 
regression (see results section for details of the model) using the model formula: affection status ~ pesticide 
exposure + coffee + age + (age ∗ pesticide exposure); +OR and CI calculated by logistic regression analysis for 
the ~10-year age difference between cases and controls. *Ever use of pesticides at home or at work, or >50% 
lifetime residence in rural areas.
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risk of PD (Fig. 1b; P = 0.008, OR = 2.36, 95% confidence interval: 1.26–4.50) in comparison to the unexposed 
group with the same genotype. Herbicide exposure led to a strongly elevated PD risk independent of genotype 
(Fig. 1c).
Discussion
Studying 24 SNPs within 15 genes involved in pesticide detoxification and transport, we found one SNP 
(rs1803274 within BCHE) that is associated with increased risk for PD in pesticide-exposed Egyptians. BCHE 
codes for the protein butyrylcholinesterase (BChE) that is alternatively designated as pseudocholinesterase or 
plasma (choline) esterase. The minor allele of rs1803274 defines the K-variant (Kalow variant) of BCHE21, which 
has been shown to reduce the activity of functional BChE in serum by 33%22,23.
Similar to acetylcholinesterase (AChE), BChE hydrolyses choline esters, e.g. the neurotransmitter acetylcho-
line (ACh). BChE is 10-fold more common in the body than AChE, yet it does not have unique physiological 
functions that cannot be compensated by other enzymes. It does, however, play an important role as a bioscaven-
ger protecting against organophosphate and carbamate toxicity24. These pesticides prevent degradation of ACh 
thus causing its accumulation and overstimulation of nerves and muscles with resulting toxic effects25. By binding 
to pesticides, BChE reduces the amount of active substances that can interfere with AChE to induce acute toxicity, 
or other esterases (e.g. neuropathy target esterase) to induce chronic neurotoxicity26.
In our study, insecticides but not herbicides significantly increased PD risk in carriers of the K-variant of 
BCHE. Insecticides used in Egypt are mainly organophosphates (e.g. chlorpyriphos) and carbamates (e.g. car-
bofuran) that are insufficiently “bioscavenged” by the K-variant of BCHE presumably explaining the observed 
increased risk for PD. In contrast, herbicides are mainly pyrimidines (e.g. bispyribac) and organochlorines (e.g. 
acetochlor) that do not interact with BChE.
One previous study reported an increased number of individuals with homozygosity for K-variant BCHE 
among PD patients compared to age-matched controls (P = 0.051)27. This finding, however, has not been con-
firmed so far28. In our sample, K-variant BCHE was also not associated with an increased risk for PD by itself, but 
Protective 
measure
PD cases 
(n = 87)
Controls 
(n = 69) OR 95% CI P-Value
Wearing gloves during work
   Yes [n (%)] 33 (37.9) 44 (63.8) 0.35 (0.18–0.66) 0.002
   No [n (%)] 54 (62.1) 25 (36.2)
Washing hands after work
   Yes [n (%)] 67 (77.0) 66 (95.7) 0.15 (0.03–0.47) 0.003
   No [n (%)] 20 (23.0) 3 (4.3)
Changing clothes after work
   Yes [n (%)] 17 (19.5) 13 (18.8) 1.05 (0.47–2.37) 0.912
   No [n (%)] 70 (80.5) 56 (81.2)
Shower after work
   Yes [n (%)] 10 (11.5) 15 (21.7) 0.47 (0.19–1.07) 0.088
   No [n (%)] 77 (88.5) 54 (78.3)
Table 3. Influence of protective measures on the risk for PD. Odds ratio (OR), 95% confidence interval (CI) and 
P- value were calculated using logistic regression.
SNP Model
SNP main effect Interaction
OR 95% CI P-Value P-Value
Complete sample – pesticide exposed vs. non-exposed
   rs1126680 dominant 0.38 (0.20–0.70) 0.002 0.795
   rs1803274 dominant 0.75 (0.49–1.15) 0.187 0.007
Insecticide exposed subgroup vs. non-exposed
   rs1803274 dominant n.a. n.a. n.a. 0.002
Herbicide exposed subgroup vs. non-exposed
   rs1803274 dominant n.a. n.a. n.a. 0.893
Table 4. Variants in BCHE affecting the risk for PD and their interaction with pesticide exposure. Logistic 
regression analysis of SNP main effect and interaction with pesticides. The interaction P-value is derived 
from the interaction term between SNP and pesticide exposure. The logistic model contained SNP, pesticide 
exposure, age, coffee consumption and the interaction between pesticides and SNP as well as pesticides and 
age; affection status ~ SNP + pesticide exposure + coffee + age + (SNP ∗ pesticide exposure) + (age ∗ pesticide 
exposure); n.a. not applicable for subgroup analysis.
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it possibly facilitated pesticide-induced development of PD owing to the reduced activity and thus less effective 
bioscavenging property of the K-variant BCHE.
Another SNP within BCHE, i.e. rs1126680, decreased PD risk in both, pesticide-exposed or unexposed indi-
viduals. This is not surprising since rs1126680 does not affect activity and function of BChE even in organo-
phosphate pesticide exposed individuals29. Our findings on BChE, however, are not contradictory. In fact they 
highlight the different roles and functions of BChE under various conditions. On the one hand, BChE acts as a 
bioscavenger under pesticide-exposed conditions, backing AChE and protecting the brain against toxic effects26. 
However, it has recently been discovered that BChE has its own physiological role affecting brain homeostasis30. 
More important, recent studies proved that BChE might play certain roles in neurodegenerative diseases pathol-
ogy31. However, the functional effects of BCHE rs1126680 in this context are unknown so far, but should be 
elucidated in future investigations.
Since we did not actively match the PD and control groups for age, we assessed the influence of the factors 
pesticide exposure, coffee consumption, age, and age × pesticide interaction by logistic regression analysis. This 
approach confirmed pesticide exposure to increase the risk for PD (Table 2), which is consistent with previous 
observations in different populations2,5. Our estimate for pesticide exposure (OR = 7.09, 95% confidence interval: 
1.12–44.01) is at the upper end of the range reported in prior studies (OR range: 1.5–7.0)6 for pesticide exposure 
as risk factor of PD but the large confidence interval suggests a high degree of uncertainty concerning the exact 
value. Studying the efficacy of protective measures in participants working with pesticides in agriculture, we 
found that wearing gloves during work and washing hands after work reduced the risk for PD (Table 3). This is in 
line with a previous study showing that glove use and hygiene habits are able to reduce the risk of PD associated 
with certain pesticides32. Additionally, there is convincing evidence that the hands are the most contaminated 
anatomical region among people working with pesticides33. Also, it was shown that different pesticides are rapidly 
absorbed by the skin34 emphasizing that glove use can protect from direct pesticide exposure and thus the risk to 
develop PD.
Furthermore, we found the well-established protective effect of coffee against PD in the present study as well. 
In contrast to previous reports, however, we did not find a protective effect of tobacco smoking. This might be due 
to a possible pesticide contamination of tobacco products in Egypt26.
We also identified a higher rate of illiteracy among PD patients as compared to controls. This is consistent 
with a previous door-to-door study in an Egyptian governorate that revealed a crude prevalence rate of PD of 
1,103/100,000 among illiterates, as opposed to 557/100,000 in the general population18. Such correlation has not 
been found in other studies that were mainly conducted in highly industrialized nations. Given that illiteracy was 
collinear to pesticide exposure in our study, a high degree of illiteracy in pesticide-exposed peasants and less strict 
adherence to safety measures in this poorly educated group might partially explain the increased risk of illiteracy 
in Egyptian PD patients. Furthermore, the previously described increased risk for PD in people drinking well 
water was collinear with pesticide exposure. Therefore, illiteracy and well water drinking are most likely indica-
tors for pesticide exposure in our sample.
The present study confirms pesticide exposure as a risk factor and coffee consumption as a protective factor 
for PD in an Egyptian population. rs1126680 in BCHE decreased the risk for PD regardless of pesticide exposure, 
Figure 1. The SNP rs1803274 in BCHE increases the risk for PD in pesticide-exposed individuals. Effect of 
pesticide exposure on PD risk per genotype in the dominant model. The statistical measures are reported with 
reference to the same genotype (wt = wildtype/wildtype), (var = wildtype/variant or variant/variant) without 
pesticide exposure for which the odds-ratio is per definition 1. Odds-ratios are found in the upper right 
corner of the bars and 95% confidence intervals of the odds-ratios are indicated below and above the error 
bars. (a) Analysis of the whole sample comparing pesticide exposed to unexposed individuals. (b) Analysis of 
the subgroup of insecticide only exposed subgroup comparing insecticide exposed to unexposed individuals. 
(c) Analysis of the subgroup of herbicide and other pesticide exposed individuals comparing this group to 
unexposed individuals.
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and rs1803274 in BCHE (K-variant) increased the risk for PD in individuals exposed to pesticides, particularly to 
insecticides, such as organophosphates and carbamates. This finding provides a basis to identify persons at risk 
for individualized preventive measures.
Methods
Ethics approval. The present study was approved by the ethics committee of Mansoura University, Egypt and 
the Technical University of Munich, Germany and conducted in accordance with the Declaration of Helsinki and 
all relevant guidelines and regulations. All study subjects provided written informed consent.
Study population. PD patients and controls without neurodegenerative disease were enrolled between 
January 2013 and December 2015 from the collaborating Neurology Departments of the Universities Mansoura, 
Ain Shams, Assiut, Sohag, Tanta and Zagazig. Participants underwent a standardized clinical assessment by con-
sultant neurologists specialized in movement disorders. Patients with PD were diagnosed using the UK Brain 
Bank Criteria35. Patients with atypical, secondary or familial forms of Parkinsonism or other neurodegenerative 
diseases were excluded. The modified Hoehn & Yahr stage was ascertained in the on-medication state. Controls 
without neurodegenerative diseases, as ascertained by history and neurological examination, were recruited from 
attendants of the collaborating hospitals (healthy visitors or patients without neurodegenerative diseases).
Questionnaire data collection. Data about environmental factors assumed to modify the risk of PD was 
collected by trained study assistants in structured interviews using a standardized questionnaire. The question-
naire included the following sections: General information (sex, age, date of birth, ethnicity), disease history 
(year of diagnosis, disease duration, medication, family history), residence history (duration of rural or urban 
living), education (literacy, years of education), occupation history (occupation learnt, working history), nutrition 
habits (coffee, black tea), smoking habits (years and quantity of smoking, cigarette or shisha use), pesticides used 
at home or at work (duration, frequency, type of pesticides (insecticides, fungicides, herbicides), and pesticide 
handling (safety precautions, hygienic measures). Some items of the questionnaire were adapted from the risk 
factor questionnaires of the National Institute of Neurological Disorders and Stroke (NINDS, www.commondata-
elements.ninds.nih.gov/pd.aspx#tab=Data-Standards). Other factors were added to the questionnaire because of 
their prior epidemiological association with PD2,5. Participants were considered as pesticide-exposed if pesticides 
were ever used at home or at work or if they resided in a rural area for more than 50% of their lifetime.
Sample preparation and genotyping. Blood-cell-derived genomic DNA (80–100 ng/µL) was gen-
otyped with the EP1 platform on 96.96 Dynamic Array and read by Fluidigm EP1 Genetic Analysis Scanner 
(Fluidigm Corporation, San Francisco, CA). Twenty-four Candidate SNPs were chosen in genes related to pesti-
cide detoxification [CYP1B1 (rs1056836)36, CYP2B6 (rs3745274)37, CYP2C9 (rs1799853, rs1057910)32, CYP2C18 
(rs2296680)38, CYP2E1 (rs2070676)39, PON1 (rs662, rs854560, rs854572)40, GSTO1 (rs11191972, rs4925)41, 
GSTO2 (rs2297235, rs156697)41, NAT1 (rs5030839, rs4987076)42,43, NAT2 (rs15561)43, NQO1 (rs1800566)9, 
COMT (rs4680)36, BCHE (rs1803274, rs1799807, rs1126680)24,29,44, PLA2G6 (CM1211192)45] and pesticide 
transport [SLC6A3 (rs27072, rs2550956)14,46]. Assays include tagged, allele-specific PCR forward-primers and a 
common reverse primer. Genotypes were determined by using allele specific fluorescent probes (FAM and HEX), 
which were detected by the EP1 scanner. Data was analyzed by the Fluidigm SNP Genotyping Analysis Software 
to obtain genotype calls. Automatic calls that did not appear clear were either amended manually or uncalled. The 
overall call confidence was ≥98.5%.
Quality control of genetic data. Genetic data quality control was performed using PLINK 1.9 (www.
cog-genomics.org/plink1.9/). First all samples were excluded in which >10% of genotypes were not reliably 
determined. Subsequently all markers that could not be genotyped in >10% of samples, markers with a minor 
allele frequency <1% and markers with a Hardy-Weinberg P-value < 0.0001 were removed. Quality control of 
genetic data led to a reduction in sample size from 861 in the analysis of demographic and environmental data to 
766 samples included in the analysis of genetic data.
Statistical analysis. Statistical analyses were performed with the statistics software R version 3.3.3 
(www.r-project.org). Numbers of study participants in Table 1 were obtained by tabulation. Numbers of study 
participants positive/negative for more than one variable as found in the results section were calculated by 
cross-tabulation. Most data were analyzed using logistic regression analyses with models specified in the results 
section. Logistic regression was performed in base R using the “glm” command, the family “binomial”, and the 
link function “logit”. Interaction of variables was analyzed by introducing interaction terms into the logistic 
regression analysis for the parameters indicated in the results section. P-values for interactions are if not stated 
otherwise the P-values of the interaction term. To estimate the P-value and odds-ratios for pesticide exposure 
in the rs1803274 wildtype (wt/wt) and variant carriers (wt/var and var/var) we stratified the sample accord-
ing to these genotypes and performed a logistic regression for the independent variable pesticide exposure. For 
demographic and environmental variables, a P-value of <0.05 was considered significant. For genetic variables, a 
P-value of <0.01 was regarded as significant. A formal correction for multiple testing was not performed because 
all analyzed variants were candidate variants already described in the context of pesticide exposure by previous 
studies.
Data Availability
The data that support the findings of this study are available from the corresponding author.
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